Bellerophon Therapeutics Inc (BLPH)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Fabian Tenenbaum
Employees:
17
184 LIBERTY CORNER ROAD, SUITE 302, WARREN, NJ 07059
908-574-4770

Bellerophon Therapeutics, Inc. engages in developing products at the intersection of drugs and devices. Its products are using in the treatment of cardiopulmonary and cardiac diseases. The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device. BCM is based on placebo-controlled clinical trial designed to support CE mark registration in the European Union. Bellerophon Therapeutics was founded in 2009 and is headquartered in Warren, NJ.

Data derived from most recent annual or quarterly report
Market Cap 36.505 Million Shares Outstanding9.506 Million Avg 30-day Volume 44.892 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 9.75 / 3.66 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from BLPH instead.

View recent insider trading info

Funds Holding BLPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BLPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LACCONA NICHOLAS CONTROLLER, (PFO & PAO)

0 2021-09-30 1

PUISSANCE LIFE SCIENCE OPPORTUNITIES FUND VI

PUISSANCE CAPITAL FUND (GP) LLC

PUISSANCE CAPITAL MANAGEMENT LP

PUISSANCE CAPITAL MANAGEMENT (GP) LLC

WANG THEODORE T

  • Director
  • 10% Owner
1,771,262 2021-06-07 2

PEACOCK JONATHAN M

157,033 2021-03-31 1

NEW MOUNTAIN INVESTMENTS II, LLC

NEW MOUNTAIN CAPITAL, L.L.C.

KLINSKY STEVEN B

609,231 2021-03-18 1

BENNETT MATTHEW

  • Director
0 2020-09-10 0

BRUDER SCOTT P

  • Director
0 2020-09-10 0

MOURA ANDRE V.

  • Director
0 2020-09-10 0

AMIN NASEEM

  • Director
0 2020-09-10 0

CLOYD MARY ANN

  • Director
0 2020-09-10 0

WANG THEODORE T

  • Director
  • 10% Owner
0 2020-09-10 2

TEUFEL CRISPIN

  • Director
0 2020-09-10 0

FARES WASSIM CHIEF MEDICAL OFFICER

  • Officer
0 2020-09-10 0

PUISSANCE CROSS-BORDER OPPORTUNITIES III LLC

PUISSANCE CAPITAL FUND (GP) LLC

PUISSANCE CAPITAL MANAGEMENT LP

PUISSANCE CAPITAL MANAGEMENT (GP) LLC

WANG THEODORE T

  • Director
  • 10% Owner
0 2020-04-17 0

TENENBAUM FABIAN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
407,459 2019-11-15 0

FERNANDES PETER CHIEF REGULATORY & SAFETY OFFR

  • Officer
182,022 2019-11-15 0

DEKKER MARTIN VP OF ENGINEERING & MANUF

  • Officer
124,619 2019-11-15 0

SHAH PARAG SURESH VP OF BUSINESS OPERATIONS

  • Officer
105,606 2019-11-15 0

KORNER ASSAF CFO

  • Officer
66,078 2019-11-15 0

VENROCK ASSOCIATES IV L P

VENROCK ENTREPRENEURS FUND IV L P

VEF MANAGEMENT IV, LLC

KOH BONG Y

VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

VENROCK MANAGEMENT IV, LLC

VENROCK PARTNERS MANAGEMENT, LLC

VENROCK PARTNERS, L.P.

VHCP CO-INVESTMENT HOLDINGS II, LLC

VHCP MANAGEMENT II, LLC

  • 10% Owner
No longer subject to file 2019-10-24 0

VENROCK ASSOCIATES IV L P

VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.

VHCP CO-INVESTMENT HOLDINGS III, LLC

SHAH NIMISH P

VHCP MANAGEMENT III, LLC

  • 10% Owner
No longer subject to file 2019-10-24 0

EDMONDS AMY VP CLINICAL OPERATIONS & ADMIN

  • Officer
0 2019-09-26 0

VENROCK ASSOCIATES IV L P

SHAH NIMISH P

  • 10% Owner
6,541,163 2018-08-14 0

TASSE DANIEL

  • Director
182,604 2018-06-21 0

LUEHRING JENS

  • Director
95,213 2018-06-21 0

QUINN DEBORAH CHIEF MEDICAL OFFICER

  • Officer
94,070 2018-06-12 0

LINDE NORTH AMERICA, INC.

5,271,796 2017-12-31 0

SCHOEPS MEGAN PRINCIPAL FINANCIAL OFFICER

  • Officer
19,248 2017-12-13 0

WEINSTEIN ADAM

  • Director
  • 10% Owner
0 2017-09-22 0

HOLT MATTHEW S.

  • Director
  • 10% Owner
0 2016-06-17 0

ABRAMS DAVID TREASURER

  • Officer
13,116 2015-12-01 0

AGRAWAL AMIT CHIEF OPERATING OFFICER

  • Officer
0 2015-07-08 0

MEGLASSON MARTIN CHIEF SCIENTIFIC OFFICER

  • Officer
19,098 2015-05-20 0

HUENNEKENS R SCOTT

  • Director
0 2015-05-12 0

HEYRMAN REINILDE CHIEF CLINICAL DEV. OFFICER

  • Officer
0 2015-03-12 0

NAIDU MANESH CHIEF BUSINESS OFFICER

  • Officer
0 2015-03-12 0

NEW MOUNTAIN INVESTMENTS II, LLC

ALLEGHENY NEW MOUNTAIN PARTNERS L P

NEW MOUNTAIN AFFILIATED INVESTORS II LP

NEW MOUNTAIN CAPITAL, L.L.C.

NEW MOUNTAIN PARTNERS II (AIV-A) L.P.

NEW MOUNTAIN PARTNERS II (AIV-B) L.P.

NEW MOUNTAIN PARTNERS II SPECIAL (AIV-A) LP

KLINSKY STEVEN B

  • 10% Owner
4,859,885 2015-02-19 0

ARCH VENTURE FUND VI LP

ARCH VENTURE PARTNERS VI LP

ARCH VENTURE PARTNERS VI LLC

CRANDELL KEITH

BYBEE CLINTON

  • 10% Owner
No longer subject to file 2015-02-19 0

NELSEN ROBERT

  • Director
  • 10% Owner
752,994 2015-02-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-26 17:45:03 UTC -19.0733 19.1433 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-26 17:15:03 UTC -19.0733 19.1433 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-26 16:45:04 UTC -18.2473 18.3173 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-26 16:15:03 UTC -18.2473 18.3173 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-26 15:45:03 UTC -18.2473 18.3173 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-26 15:15:03 UTC -18.2473 18.3173 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-26 14:45:03 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-26 14:15:05 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-26 13:45:03 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-26 13:15:03 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-26 12:45:03 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-25 22:15:03 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-25 21:45:03 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-25 21:15:03 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-25 20:45:03 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-25 20:15:03 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-25 19:45:04 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-25 19:15:03 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-25 18:45:02 UTC -17.4855 17.5555 100000
BELLEROPHON THERAPEUTICS INC BLPH 2021-10-25 18:15:03 UTC -17.4855 17.5555 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments